{"id":40275,"date":"2026-06-20T11:14:38","date_gmt":"2026-06-20T10:14:38","guid":{"rendered":"https:\/\/usamedical.com\/en\/?post_type=product&p=40275"},"modified":"2026-08-20T15:15:46","modified_gmt":"2026-08-20T22:15:46","slug":"cbg-oil-1000-mg-30-ml","status":"publish","type":"product","link":"https:\/\/usamedical.com\/en\/product\/cbg-oil-1000-mg-30-ml\/","title":{"rendered":"CBG Oil 1,000 mg"},"content":{"rendered":"
\n

Energy. Focus. Everyday Comfort.<\/h2>\n

The core 1:1 CBG+CBD strength for a clear, engaged daytime ritual built around steady energy, sharper focus, and everyday physical comfort. Orange flavor, one 1 mL serving, and a simple 1:1, 50\/50 formula keep the experience easy to understand.<\/p>\n

\nWhat the research says<\/span><\/p>\n

An intriguing daytime signal. Still early human evidence.<\/h3>\n

A 2024 double-blind crossover field trial gave 34 healthy adults 20 mg CBG or placebo. The CBG condition showed acute anxiety- and stress-related signals plus stronger verbal-memory performance, without evidence of subjective intoxication or impairment.[1]<\/a> It was a small, short study of isolated CBG\u2014not this 1:1 CBG+CBD oil.<\/p>\n

A later randomized trial studied 25 mg and then 50 mg CBG daily in veterans with sleep problems. Sleep measures improved in both groups, but CBG did not significantly outperform placebo.[2]<\/a> That is why this page sells a clear daytime ritual rather than promising sleep or a medical result.<\/p>\n

Our honest read: CBG is worth following, especially for stress, cognition, and pharmacology questions, but broad human benefits are not established. The credible promise here is a precisely explained CBG+CBD formula, a repeatable dropper ritual, and product-specific potency evidence with its limits visible.<\/p>\n<\/div>\n

\n
1,000 mg<\/strong>Total cannabinoids per 30 mL bottle<\/span><\/div>\n
\n
Core everyday strength<\/strong>The center of the current USA Medical CBG+CBD range, with a simple 50\/50 bottle split.<\/span><\/div>\n
1:1 \u00b7 50\/50<\/strong>500 mg CBG + 500 mg CBD per bottle.<\/span><\/div>\n
33.3 mg per serving<\/strong>Total cannabinoids per standardized 1 mL serving.<\/span><\/div>\n
5% extra built in<\/strong>New batches are made to a 5% formulation-overage target.<\/span><\/div>\n<\/div>\n<\/div>\n

What CBG Is For<\/h3>\n
\n
\n

Energy. Focus. Everyday Comfort.<\/h3>\n

The core 1:1 CBG+CBD strength for a clear, engaged daytime ritual built around steady energy, sharper focus, and everyday physical comfort.<\/p>\n<\/div>\n

\n

Daytime drive + comfort<\/h3>\n

A daytime ritual designed around feeling engaged, focused, and physically comfortable through the day.<\/p>\n<\/div>\n

\n

One clear serving<\/h3>\n

Every strength uses the same 1 mL serving standard, giving each 30 mL bottle 30 measured servings.<\/p>\n<\/div>\n

\n

Research-led, never hype-led<\/h3>\n

Human CBG research is still small. We show what changed in a study and what did not.<\/p>\n<\/div>\n

\n

Orange-finished oil<\/h3>\n

Grape seed oil, hemp seed oil, and organic orange oil complete the archived formula.<\/p>\n<\/div>\n

\n

Potency record available<\/h3>\n

The archived 2023 cannabinoid report is available in Certificates, where the measured sample results and their limits stay clear without complicating the 1:1 sales story.<\/p>\n<\/div>\n<\/div>\n

Choose the Strength That Fits Your Routine<\/h3>\n
\n
Bottle strength<\/span>Range position<\/span>Bottle split<\/span><\/div>\n
500 mg<\/strong>Gentle-start strength.<\/span>250 mg CBG + 250 mg CBD.<\/span><\/div>\n
1,000 mg<\/strong>Core everyday strength.<\/span>500 mg CBG + 500 mg CBD.<\/span><\/div>\n
3,000 mg<\/strong>Highest strength for experienced routines.<\/span>1,500 mg CBG + 1,500 mg CBD.<\/span><\/div>\n<\/div>\n
\n
\n

Go deeper with the Cannabinoid Encyclopedia<\/h3>\n

The Cannabinoid Encyclopedia is a separate educational project from the USA Medical team. It does not sell products. Its role here is to keep longer evidence reviews and primary sources separate from product claims.<\/p>\n

What is CBG? \u2197<\/span><\/a>
CBG and anxiety-related outcomes \u2197<\/span><\/a>
CBD vs. CBG \u2197<\/span><\/a><\/p>\n<\/div>\n

\n

Formula and food can change exposure<\/h3>\n

A human pharmacokinetic study found that dietary fat materially changed CBG exposure after a 25 mg dose.[3]<\/a> That result is not a meal instruction for this oil, but it shows why study amounts, delivery systems, and routines are not interchangeable.<\/p>\n

This formula also contains CBD. FDA identifies unresolved safety, interaction, alertness, liver, pregnancy, and quality questions for consumer CBD products.[6]<\/a><\/p>\n<\/div>\n<\/section>\n

\"CBG+CBD
Clear energy. Sharper focus. Everyday comfort.<\/figcaption><\/figure>\n
\n
\n

Works Cited<\/h2>\n<\/header>\n
\n
\n
Controlled field trial \u00b7 2024<\/span>01<\/span><\/div>\n

Acute CBG, stress, anxiety, and memory<\/h3>\n

Thirty-four healthy adults received 20 mg CBG or placebo in a double-blind crossover design. The study reported selected acute signals without subjective intoxication or impairment; it did not test this combined oil.<\/p>\n

Read on PubMed \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
Randomized trial \u00b7 2025<\/span>02<\/span><\/div>\n

CBG and sleep in veterans<\/h3>\n

Participants used 25 mg and then 50 mg CBG daily. CBG did not significantly outperform placebo on the primary sleep outcome, and five mild possibly related adverse events were reported.<\/p>\n

Read on PubMed \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
Human pharmacokinetics \u00b7 2024<\/span>03<\/span><\/div>\n

Food and delivery system affect CBG exposure<\/h3>\n

A controlled adult study found that a high-fat meal materially changed several pharmacokinetic measures after a 25 mg CBG dose, reinforcing that formulations and routines cannot be treated as equivalent.<\/p>\n

Read on PubMed \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
Comprehensive review \u00b7 2024<\/span>04<\/span><\/div>\n

CBG mechanisms and research directions<\/h3>\n

This review maps receptor, signaling, and preclinical research while emphasizing the need for more clinical evidence and a clearer human safety profile.<\/p>\n

Read on PubMed \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
Human-cell study \u00b7 2024<\/span>05<\/span><\/div>\n

Comparative liver-cell response<\/h3>\n

This laboratory study compared hemp extract, CBD, CBC, CBG, and CBN in human-derived liver cells. It raises safety questions but cannot predict an individual’s response to this product.<\/p>\n

Read on PubMed \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
Official consumer guidance<\/span>06<\/span><\/div>\n

FDA cannabis-derived product update<\/h3>\n

Because this formula contains CBD, FDA’s consumer summary on medicine interactions, alertness, liver, pregnancy, product quality, and unproven medical claims is directly relevant.<\/p>\n

Read the FDA update \u2197<\/span><\/a><\/div>\n<\/article>\n<\/div>\n